Abstract:Although iodinated contrast agents are safe and widely used, adverse events occur and questions remain about their use, safety, and interactions. Some questions are easily answered and others still require extensive investigation. For one frequent question--is informed consent necessary before all contrast media injections--the simple answer is no. Another question concerns use of contrast media in patients with prior reactions or allergies. Contrast agents can be safely used in such patients, but special care must be taken to be aware of what the previous reaction was and to be ready to treat any reaction. The protective role of pre-treatment with steroids is well established for minor reactions, but they may not prevent major reactions. It is important to realize that even life-threatening, anaphylactoid reactions are not the result of a true allergy to contrast media. Many questions arise about contrast agent-induced nephropathy. Baseline serum creatinine values should be obtained in patients who are at risk, not all patients. The incidence and natural history of contrast agent-induced nephropathy remain unclear. It occurs only in patients with compromised renal function before contrast agent injection, but even patients with normal serum creatinine levels can have renal dysfunction. Calculated creatinine clearance is a better way to determine risk and to follow this complication. The outcome in almost all patients is benign, with progression to end-stage renal disease being rare. The major risk factors, in addition to renal dysfunction, are long-standing diabetes mellitus, dehydration, and use of other nephrotoxic medications. Recent work in preventing and ameliorating contrast agent-induced nephropathy with N-acetyl cysteine, substitution of an isosmolal nonionic contrast agent, and various hydration regimens has been promising. Another common concern is use of iodinated contrast agents in pregnant or breast-feeding women. In both cases, there is no evidence of harm to the fetus or infant, but it is prudent to weigh the theoretical risks and benefits and avoid contrast agent administration unless it is truly necessary.

[Complications due to contrast agent administration: what has been confirmed in prevention?]

Intravenous Imaging Contrast Media Complications: The Basics That Every Clinician Needs to Know

Safe Use of Contrast Media: What the Radiologist Needs to Know

Risk factors and recent advances in the prevention of contrast - induced nephropathy

Clinical effectiveness of contrast medium injection protocols for 80-kV coronary and craniocervical CT angiography—a prospective multicenter observational study

Contrast media safety-an update

Toxicity of MRI and CT contrast agents

Frequently Asked Questions: Iodinated Contrast Agents

Contrast-induced Nephropathy in CT: Incidence, Risk Factors and Strategies for Prevention.

On q-Integral Transforms and Their Applications

Adverse Reactions to Contrast Material: A Canadian Update

Contraindications and Adverse Effects in Abdominal Imaging

Critical but commonly neglected factors that affect contrast medium administration in CT

Intrinsic alterations of pro‐inflammatory mediators in unstimulated and TLR‐2 stimulated keratinocytes from atopic dermatitis patients

Iodinated Contrast Media and Their Adverse Reactions

Comprehensive literature review of oral and intravenous contrast-enhanced PET/CT: a step forward?

Current evidence on prevention and management of contrast-induced nephropathy

Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation

A new mutant in the yellow-bellied cotton rat.

Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

Trends in Adverse Events After IV Administration of Contrast Media